INHIBITEURS PERK ET IRE-1A CONTRE DES TROUBLES NEURODÉVELOPPEMENTAUX
- 专利权人:
- Université de Liège
- 发明人:
- 申请号：
- EP19193344.9
- 公开号：
- EP3656382A1
- 申请日:
- 2018.01.29
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to UPR pathway inhibitors, in particular PERK and IRE-1A inhibitors for use in the prevention or treatment of neurodevelopmental disorders, such as microcephaly caused by ZIKV.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PERK AND IRE-1A INHIBITORS AGAINST NEURODEVELOPMENTAL DISORDERS
- PERK AND IRE-1A INHIBITORS AGAINST NEURODEVELOPMENTAL DISORDERS
- INTERLEUKIN-17 PATHWAY INHIBITOR FOR THE TREATMENT OF CHRONIC HPV INFECTIONS
- TRAP1 Screening method for therapeutic agent of mitochondria dysfunction using TRAP1 gene
- INHIBITORS OF THE INTERLEUKIN 17 PATHWAY FOR THE TREATMENT OF CHRONIC DISEASES DUE TO HPV
